Company
Every investor coverage indicates participated in a round Obsidian raised.
Companies Obsidian acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Obsidian. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne biotech Paradigm Biopharmaceuticals appointed FTI Consulting administrators after its Phase 3 trial failed an interim efficacy threshold, and now seeks to restructure debts via a deed of company arrangement.
Australian-founded AI vulnerability platform Nullify, now San Francisco-based, has closed a second seed round led by SYN Ventures with returning backer Black Nova; SYN's Glenn Chisholm joins its board.
Also Startup Daily